BridgeMD
Compares treatment options for Bladder Dysfunction
Official title NESA Neuromodulation Versus Transcutaneous Posterior Tibial Stimulation
ClinicalTrials.gov ID: NCT07019597
What this study is testing
- What it's testing
- Introduction: Overactive bladder (OAB) is a common condition characterized by urinary urgency, frequency, and, in some cases, urge incontinence. Non-invasive neuromodulation has emerged as an effective therapeutic option by modulating the neural pathways involved in bladder control.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Minimum criteria for a primary diagnosis of overactive bladder who have or have not received active/alternative treatments for this pathology.
- Patients with previous pharmacological treatments that have not obtained an adequate clinical response.
- Patients whose cognitive abilities are competent to participate in the study and are able to complete the study questionnaires and have given written...
- Without further contraindications for electrotherapy treatment such as serious use of pacemakers, pregnancy, internal bleeding, poor skin condition...
You likely can't join if
- Presence of urinary fistula.
- Infections in the last 12 months.
- Haematuria during the trial period.
- Pregnancy or plans to become pregnant during the study.
- Pathology of the central or peripheral nervous system (multiple sclerosis, Parkinson's disease, etc.).
- Uncontrolled diabetes.
See the full eligibility criteria
- Minimum criteria for a primary diagnosis of overactive bladder who have or have not received active/alternative treatments for this pathology.
- Patients with previous pharmacological treatments that have not obtained an adequate clinical response.
- Patients whose cognitive abilities are competent to participate in the study and are able to complete the study questionnaires and have given written consent to participate in the study.
- Without further contraindications for electrotherapy treatment such as serious use of pacemakers, pregnancy, internal bleeding, poor skin condition (ulcerations, wounds...) and/or phobia of electricity.
- Presence of urinary fistula.
- Infections in the last 12 months.
- Haematuria during the trial period.
- Pregnancy or plans to become pregnant during the study.
- Pathology of the central or peripheral nervous system (multiple sclerosis, Parkinson's disease, etc.).
- Uncontrolled diabetes.
- Currently treated with Botox injections for the bladder or within the last year.
- Current treatment with interstim or currently implanted interstim device.
- Bladder outlet obstruction.
- Urinary retention.
- Treatment with more than two antidepressants and/or multiple benzodiazepines, as well as antiepileptics.
- Contraindications for electrotherapy treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.